FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012664562> ?p ?o ?g. }

• W3012664562 endingPage "171" @default.
• W3012664562 startingPage "152" @default.
• W3012664562 abstract "Background and Purpose Chronic obstructive pulmonary disease, encompassing chronic airway obstruction and lung emphysema, is a major worldwide health problem and a severe socio‐economic burden. Evidence previously provided by our group has shown that inhibition of inducible NOS (iNOS) prevents development of mild emphysema in a mouse model of chronic tobacco smoke exposure and can even trigger lung regeneration. Moreover, we could demonstrate that pulmonary hypertension is not only abolished in cigarette smoke‐exposed iNOS −/− mice but also precedes emphysema development. Possible regenerative effects of pharmacological iNOS inhibition in more severe models of emphysema not dependent on tobacco smoke, however, are hitherto unknown. Experimental Approach We have established a mouse model using a single dose of porcine pancreatic elastase or saline, intratracheally instilled in C57BL/6J mice. Emphysema, as well as pulmonary hypertension development was determined by both structural and functional measurements. Key Results Our data revealed that (i) emphysema is fully established after 21 days, with the same degree of emphysema after 21 and 28 days post instillation, (ii) emphysema is stable for at least 12 weeks and (iii) pulmonary hypertension is evident, in contrast to smoke models, only after emphysema development. Oral treatment with the iNOS inhibitor N(6)‐(1‐iminoethyl)‐ l ‐lysine (L‐NIL) was started after emphysema establishment and continued for 12 weeks. This resulted in significant lung regeneration, evident in the improvement of emphysema and reversal of pulmonary hypertension. Conclusion and Implications Our data indicate that iNOS is a potential new therapeutic target to treat severe emphysema and associated pulmonary hypertension. LINKED ARTICLES This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.1/issuetoc" @default.
• W3012664562 created "2020-03-27" @default.
• W3012664562 creator A5011005875 @default.
• W3012664562 creator A5012081620 @default.
• W3012664562 creator A5016511599 @default.
• W3012664562 creator A5030309692 @default.
• W3012664562 creator A5037470603 @default.
• W3012664562 creator A5039470820 @default.
• W3012664562 creator A5045795242 @default.
• W3012664562 creator A5050068072 @default.
• W3012664562 creator A5052349036 @default.
• W3012664562 creator A5055255847 @default.
• W3012664562 creator A5057524424 @default.
• W3012664562 creator A5061038543 @default.
• W3012664562 creator A5061922297 @default.
• W3012664562 creator A5068850675 @default.
• W3012664562 creator A5077949051 @default.
• W3012664562 creator A5083839456 @default.
• W3012664562 creator A5085910452 @default.
• W3012664562 creator A5091742786 @default.
• W3012664562 date "2020-04-28" @default.
• W3012664562 modified "2023-10-18" @default.
• W3012664562 title "Amelioration of elastase‐induced lung emphysema and reversal of pulmonary hypertension by pharmacological iNOS inhibition in mice" @default.
• W3012664562 cites W1593555249 @default.
• W3012664562 cites W1601042192 @default.
• W3012664562 cites W1747867097 @default.
• W3012664562 cites W1775181078 @default.
• W3012664562 cites W1862464476 @default.
• W3012664562 cites W1893795464 @default.
• W3012664562 cites W1944587035 @default.
• W3012664562 cites W1988119527 @default.
• W3012664562 cites W1989807292 @default.
• W3012664562 cites W1995457093 @default.
• W3012664562 cites W1999717948 @default.
• W3012664562 cites W2000904152 @default.
• W3012664562 cites W2013322023 @default.
• W3012664562 cites W2018076136 @default.
• W3012664562 cites W2018449993 @default.
• W3012664562 cites W2018762529 @default.
• W3012664562 cites W2021042078 @default.
• W3012664562 cites W2021176122 @default.
• W3012664562 cites W2022436542 @default.
• W3012664562 cites W2035837921 @default.
• W3012664562 cites W2038945158 @default.
• W3012664562 cites W2050308681 @default.
• W3012664562 cites W2052506174 @default.
• W3012664562 cites W2056237344 @default.
• W3012664562 cites W2058137293 @default.
• W3012664562 cites W2067906203 @default.
• W3012664562 cites W2070978254 @default.
• W3012664562 cites W2072589179 @default.
• W3012664562 cites W2095954284 @default.
• W3012664562 cites W2104194752 @default.
• W3012664562 cites W2110287460 @default.
• W3012664562 cites W2114816952 @default.
• W3012664562 cites W2116949012 @default.
• W3012664562 cites W2122616097 @default.
• W3012664562 cites W2124583791 @default.
• W3012664562 cites W2125619852 @default.
• W3012664562 cites W2127070461 @default.
• W3012664562 cites W2128073106 @default.
• W3012664562 cites W2129513537 @default.
• W3012664562 cites W2138563089 @default.
• W3012664562 cites W2145341186 @default.
• W3012664562 cites W2152350096 @default.
• W3012664562 cites W2159267296 @default.
• W3012664562 cites W2166442977 @default.
• W3012664562 cites W2177184392 @default.
• W3012664562 cites W2254227479 @default.
• W3012664562 cites W2261977399 @default.
• W3012664562 cites W2269467896 @default.
• W3012664562 cites W2309424254 @default.
• W3012664562 cites W2395807607 @default.
• W3012664562 cites W2528274437 @default.
• W3012664562 cites W2741162779 @default.
• W3012664562 cites W2756324351 @default.
• W3012664562 cites W2766277020 @default.
• W3012664562 cites W2771328536 @default.
• W3012664562 cites W2791419854 @default.
• W3012664562 cites W2792530460 @default.
• W3012664562 cites W2987819628 @default.
• W3012664562 cites W4231651824 @default.
• W3012664562 doi "https://doi.org/10.1111/bph.15057" @default.
• W3012664562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32201936" @default.
• W3012664562 hasPublicationYear "2020" @default.
• W3012664562 type Work @default.
• W3012664562 sameAs 3012664562 @default.
• W3012664562 citedByCount "14" @default.
• W3012664562 countsByYear W30126645622020 @default.
• W3012664562 countsByYear W30126645622021 @default.
• W3012664562 countsByYear W30126645622022 @default.
• W3012664562 countsByYear W30126645622023 @default.
• W3012664562 crossrefType "journal-article" @default.
• W3012664562 hasAuthorship W3012664562A5011005875 @default.
• W3012664562 hasAuthorship W3012664562A5012081620 @default.
• W3012664562 hasAuthorship W3012664562A5016511599 @default.
• W3012664562 hasAuthorship W3012664562A5030309692 @default.
• W3012664562 hasAuthorship W3012664562A5037470603 @default.

• next